The AGBT (Advances in Genome Biology and Technology ... from the meeting is critical to understanding where the world of NGS, spatial, single cell, and multiomics is heading.

NGS revenue totaled $48.6 million ... positioning itself as a leader in synthetic biology and genomics. Read the full Earnings Call Transcript ...

Price drop reflects efficiency gains from Co.’s cell-free cloning tech & new facility, where automation & ML have increased ...

The DNA polymerase market in the United States is poised for significant expansion, with projections indicating a market size of USD 148.7 million by 2025 and a compound annual growth rate (CAGR) of 5 ...

ACT Genomics Co. Limited, Asia's foremost provider of next-generation sequencing (NGS) precision oncology, is proud to ...